1. Home
  2. MAIA vs MNTX Comparison

MAIA vs MNTX Comparison

Compare MAIA & MNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • MNTX
  • Stock Information
  • Founded
  • MAIA 2018
  • MNTX 1993
  • Country
  • MAIA United States
  • MNTX United States
  • Employees
  • MAIA N/A
  • MNTX N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • MNTX Industrial Machinery/Components
  • Sector
  • MAIA Health Care
  • MNTX Technology
  • Exchange
  • MAIA Nasdaq
  • MNTX Nasdaq
  • Market Cap
  • MAIA 65.9M
  • MNTX 77.7M
  • IPO Year
  • MAIA 2022
  • MNTX 2005
  • Fundamental
  • Price
  • MAIA $2.13
  • MNTX $5.72
  • Analyst Decision
  • MAIA
  • MNTX Hold
  • Analyst Count
  • MAIA 0
  • MNTX 1
  • Target Price
  • MAIA N/A
  • MNTX $5.80
  • AVG Volume (30 Days)
  • MAIA 163.9K
  • MNTX 118.8K
  • Earning Date
  • MAIA 11-12-2024
  • MNTX 11-07-2024
  • Dividend Yield
  • MAIA N/A
  • MNTX N/A
  • EPS Growth
  • MAIA N/A
  • MNTX 248.43
  • EPS
  • MAIA N/A
  • MNTX 0.46
  • Revenue
  • MAIA N/A
  • MNTX $294,775,000.00
  • Revenue This Year
  • MAIA N/A
  • MNTX $6.97
  • Revenue Next Year
  • MAIA N/A
  • MNTX $12.08
  • P/E Ratio
  • MAIA N/A
  • MNTX $12.56
  • Revenue Growth
  • MAIA N/A
  • MNTX 1.10
  • 52 Week Low
  • MAIA $0.82
  • MNTX $3.07
  • 52 Week High
  • MAIA $5.99
  • MNTX $9.16
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 33.62
  • MNTX 61.84
  • Support Level
  • MAIA $2.42
  • MNTX $5.65
  • Resistance Level
  • MAIA $3.48
  • MNTX $5.71
  • Average True Range (ATR)
  • MAIA 0.29
  • MNTX 0.03
  • MACD
  • MAIA -0.06
  • MNTX -0.02
  • Stochastic Oscillator
  • MAIA 1.46
  • MNTX 53.85

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About MNTX Manitex International Inc.

Manitex International Inc through its subsidiaries is engaged in the design, manufacture, and distribution of engineered lifting solutions. Its products include boom trucks, truck cranes, and sign cranes. The company's segments include Lifting Equipment and Rental Equipment. It generates maximum revenue from the Lifting Equipment segment. Geographically, it derives majority of its revenue from the United States.

Share on Social Networks: